• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[大剂量尼卡地平对破裂脑动脉瘤患者的影响]

[Effect of high dose nicardipine in patients with ruptured cerebral aneurysm].

作者信息

Kitano H, Matsuda M

机构信息

Department of Neurosurgery, Shiga University of Medical Science.

出版信息

Nihon Geka Hokan. 1993 Nov 1;62(6):287-93.

PMID:8092922
Abstract

We studied the effect of high dose nicardipine in patients with ruptured cerebral aneurysm. Seventeen patients were treated with intravenous infusion of nicardipine, 23.0-124.4 mg/day, for 15 days, which was started within 72 hours after onset of subarachnoid hemorrhage (SAH). Aneurysmal neck was clipped within 96 hours after SAH. Five patients were excluded because of discontinuation of treatment due to hypotension and intra- or postoperative complication. Among the 12 patients, symptomatic vasospasm was observed in 6, and one of them had a permanent deficit. Severe angiographic vasospasm was observed in 3 patients, but two of them did not show symptomatic vasospasm. From this study we can't draw any conclusion about effect of nicardipine on prevention of symptomatic and angiographic vasospasm after SAH, because of small number of cases.

摘要

我们研究了大剂量尼卡地平对破裂脑动脉瘤患者的影响。17例患者静脉输注尼卡地平,剂量为23.0 - 124.4毫克/天,持续15天,在蛛网膜下腔出血(SAH)发病后72小时内开始给药。SAH后96小时内夹闭动脉瘤颈。5例患者因低血压及术中或术后并发症而停止治疗被排除。在这12例患者中,6例出现症状性血管痉挛,其中1例有永久性神经功能缺损。3例患者出现严重血管造影血管痉挛,但其中2例未出现症状性血管痉挛。由于病例数较少,本研究无法就尼卡地平对SAH后预防症状性和血管造影血管痉挛的效果得出任何结论。

相似文献

1
[Effect of high dose nicardipine in patients with ruptured cerebral aneurysm].[大剂量尼卡地平对破裂脑动脉瘤患者的影响]
Nihon Geka Hokan. 1993 Nov 1;62(6):287-93.
2
[The effects of ticlopidine and nicardipine on the prevention of symptomatic vasospasm after aneurysmal rupture].
No Shinkei Geka. 1988 May;16(6):741-6.
3
A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.大剂量静脉注射尼卡地平治疗动脉瘤性蛛网膜下腔出血的随机对照试验。合作动脉瘤研究报告。
J Neurosurg. 1993 Apr;78(4):537-47. doi: 10.3171/jns.1993.78.4.0537.
4
[Preliminary clinical trial of intrathecal rt-PA (TD-2061) for the prevention of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage].
No To Shinkei. 1992 Nov;44(11):1001-8.
5
Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhage.静脉注射尼卡地平治疗动脉瘤性蛛网膜下腔出血患者的剂量递增研究。
J Neurosurg. 1988 Mar;68(3):393-400. doi: 10.3171/jns.1988.68.3.0393.
6
[High dose nicardipine therapy for delayed cerebral vasospasm after aneurysmal subarachnoid hemorrhage].
No Shinkei Geka. 1993 Nov;21(11):999-1003.
7
Hemodynamic management and outcome of patients treated for cerebral vasospasm with intraarterial nicardipine and/or milrinone.颅内动脉应用尼卡地平及/或米力农治疗脑血管痉挛患者的血流动力学管理和结局。
Anesth Analg. 2010 Mar 1;110(3):895-902. doi: 10.1213/ANE.0b013e3181cc9ed8.
8
Calcium antagonists in the management of patients with aneurysmal subarachnoid hemorrhage: a review.钙拮抗剂在动脉瘤性蛛网膜下腔出血患者管理中的应用:综述
Angiology. 1990 Nov;41(11 Pt 2):1010-6.
9
[Continuous intrathecal administration of nicardipine using a portable infusion pump system for management of vasospasm after subarachnoid hemorrhage].[使用便携式输注泵系统持续鞘内注射尼卡地平治疗蛛网膜下腔出血后血管痉挛]
No Shinkei Geka. 2001 Jan;29(1):23-30.
10
Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage.预防性鞘内注射尼卡地平对重症动脉瘤性蛛网膜下腔出血患者血管痉挛的影响。
Acta Neurochir (Wien). 1994;131(1-2):19-25. doi: 10.1007/BF01401450.